{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:50:49Z","timestamp":1784152249562,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ucl.2024.07.011","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T20:50:01Z","timestamp":1729025401000},"page":"111-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Urologic Imaging of the Bladder"],"prefix":"10.1016","volume":"52","author":[{"given":"Haleh","family":"Amirian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe B.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borna","family":"Dabiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Alessandrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ucl.2024.07.011_bib2","author":"Ferlay"},{"issue":"2","key":"10.1016\/j.ucl.2024.07.011_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1148\/radiol.2502080534","article-title":"What is the current role of CT urography and MR urography in the evaluation of the urinary tract?","volume":"250","author":"Silverman","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.ucl.2024.07.011_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejrad.2017.10.021","article-title":"Upper tract urothelial cancer","volume":"98","author":"Froemming","year":"2018","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.ucl.2024.07.011_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061396","article-title":"Imaging and Management of Bladder Cancer","volume":"13","author":"Wong","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ucl.2024.07.011_bib6","first-page":"778","article-title":"Microhematuria: AUA\/SUFU guideline","volume":"204","author":"Barocas","year":"2020","journal-title":"J\u00a0Urol"},{"issue":"4 Pt 1","key":"10.1016\/j.ucl.2024.07.011_bib7","first-page":"1231","article-title":"Identifying risk factors for potentially avoidable complications following radical cystectomy","volume":"174","author":"Hollenbeck","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2024.07.011_bib8","first-page":"967","article-title":"Risk of Radiation from Computerized Tomography Urography in the Evaluation of Asymptomatic Microscopic Hematuria","volume":"200","author":"Yecies","year":"2018","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2214\/AJR.14.13862","article-title":"A\u00a0Survey of Radiation Doses in CT Urography Before and After Implementation of Iterative Reconstruction","volume":"205","author":"van der Molen","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.ucl.2024.07.011_bib10","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s00261-017-1195-3","article-title":"Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer","volume":"42","author":"Choe","year":"2017","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"10.1016\/j.ucl.2024.07.011_bib11","first-page":"899","article-title":"The Harms of Hematuria Evaluation: Modeling the Risk-Benefit of Using Split Bolus Computerized Tomography Urography to Reduce Radiation Exposure in a Theoretical Cohort","volume":"202","author":"Dallmer","year":"2019","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib12","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00330-019-06521-0","article-title":"Examining the upper urinary tract in patients with hematuria-time to revise the CT urography protocol?","volume":"30","author":"Rud","year":"2020","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.ucl.2024.07.011_bib13","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00330-019-06530-z","article-title":"Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging","volume":"30","author":"Rouviere","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ucl.2024.07.011_bib14","author":"Network"},{"issue":"7492","key":"10.1016\/j.ucl.2024.07.011_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.ucl.2024.07.011_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1148\/rg.262055172","article-title":"Neoplasms of the Urinary Bladder: Radiologic-Pathologic Correlation","volume":"26","author":"Wong-You\u2013Cheong","year":"2006","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.ucl.2024.07.011_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 23","key":"10.1016\/j.ucl.2024.07.011_bib19","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.29047","article-title":"Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: a review of SEER data, 2004-2010","volume":"120","author":"Charlton","year":"2014","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ucl.2024.07.011_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.7326\/0003-4819-155-4-201108160-00008","article-title":"Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement","volume":"155","author":"Moyer","year":"2011","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.ucl.2024.07.011_bib21","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/j.jacr.2020.01.028","article-title":"ACR Appropriateness Criteria\u00ae Hematuria","volume":"17","author":"Wolfman","year":"2020","journal-title":"J\u00a0Am Coll Radiol"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1148\/radiol.2491071860","article-title":"Bladder cancer detection with CT urography in an Academic Medical Center","volume":"249","author":"Sadow","year":"2008","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ucl.2024.07.011_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/21681805.2015.1026937","article-title":"Bladder cancer detection in patients with gross haematuria: Computed tomography urography with enhancement-triggered scan versus flexible cystoscopy","volume":"49","author":"Helenius","year":"2015","journal-title":"Scand J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00261-017-1249-6","article-title":"Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results","volume":"43","author":"Trinh","year":"2018","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clinimag.2014.10.004","article-title":"Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes","volume":"39","author":"Di Paolo","year":"2015","journal-title":"Clin Imaging"},{"issue":"12","key":"10.1016\/j.ucl.2024.07.011_bib27","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1016\/j.ejrad.2012.06.010","article-title":"Prospective evaluation of MRI, 11C-acetate PET\/CT and contrast-enhanced CT for staging of bladder cancer","volume":"81","author":"Vargas","year":"2012","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.ucl.2024.07.011_bib28","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2214\/AJR.16.17114","article-title":"Role of Imaging in the Local Staging of Urothelial Carcinoma of the Bladder","volume":"208","author":"Lee","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"1112","key":"10.1016\/j.ucl.2024.07.011_bib29","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200116","article-title":"Staging of bladder cancer with multiparametric MRI","volume":"93","author":"Juri","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ucl.2024.07.011_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2020.07.021","article-title":"Diagnostic Accuracy of Multiparametric MRI for Local Staging of Bladder Cancer: A Systematic Review and Meta-Analysis","volume":"145","author":"Cornelissen","year":"2020","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ucl.2024.07.011_bib31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/bju.14366","article-title":"Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis","volume":"122","author":"Gandhi","year":"2018","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2024.07.011_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/s1677-5538.ibju.2021.0560","article-title":"VI-RADS score system - A primer for urologists","volume":"48","author":"Nicola","year":"2022","journal-title":"Int Braz J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib34","doi-asserted-by":"crossref","DOI":"10.1148\/rg.220034","article-title":"Urinary Bladder Masses, Rare Subtypes, and Masslike Lesions: Radiologic-Pathologic Correlation","volume":"43","author":"Hoegger","year":"2023","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.ucl.2024.07.011_bib35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00261-021-03365-5","article-title":"Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report","volume":"47","author":"Pecoraro","year":"2022","journal-title":"Abdom Radiol (NY)"},{"issue":"9","key":"10.1016\/j.ucl.2024.07.011_bib36","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.acra.2012.05.004","article-title":"Comparative effectiveness of imaging modalities for the diagnosis of upper and lower urinary tract malignancy: a critically appraised topic","volume":"19","author":"Razavi","year":"2012","journal-title":"Acad Radiol"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/21681805.2014.981203","article-title":"Diagnosis of bladder tumours in patients with macroscopic haematuria: a prospective comparison of split-bolus computed tomography urography, magnetic resonance urography and flexible cystoscopy","volume":"49","author":"Gandrup","year":"2015","journal-title":"Scand J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.ucl.2024.07.011_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112951","article-title":"Assessing the Performance of 18F-FDG PET\/CT in Bladder Cancer: A Narrative Review of Current Evidence","volume":"15","author":"Bacchiani","year":"2023","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.ucl.2024.07.011_bib40","doi-asserted-by":"crossref","first-page":"787.e17","DOI":"10.1016\/j.urolonc.2021.04.024","article-title":"Clinical value of 18FDG PET\/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer","volume":"39","author":"Civelek","year":"2021","journal-title":"Urol Oncol"},{"issue":"12","key":"10.1016\/j.ucl.2024.07.011_bib41","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1007\/s00261-019-02148-3","article-title":"Advanced urothelial cancer: a radiology update","volume":"44","author":"Alessandrino","year":"2019","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.euf.2017.06.005","article-title":"Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and (18)F-fluorodeoxyglucose Positron Emission Tomography\/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up","volume":"5","author":"Vind-Kezunovic","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"6","key":"10.1016\/j.ucl.2024.07.011_bib43","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00261-013-0024-6","article-title":"Surveillance of patients with bladder cancer following cystectomy: yield of CT urography","volume":"38","author":"Shinagare","year":"2013","journal-title":"Abdom Imaging"},{"issue":"2","key":"10.1016\/j.ucl.2024.07.011_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000030361","article-title":"Patterns of metastasis in muscle-invasive bladder cancer (pT2-4): An autopsy study on 367 patients","volume":"62","author":"Wallmeroth","year":"1999","journal-title":"Urol Int"},{"issue":"2","key":"10.1016\/j.ucl.2024.07.011_bib45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/RCT.0b013e31820d7a37","article-title":"Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location","volume":"35","author":"Shinagare","year":"2011","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1102\/1470-7330.2011.0017","article-title":"Urinary bladder: normal appearance and mimics of malignancy at CT urography","volume":"11","author":"Shinagare","year":"2011","journal-title":"Cancer Imag"},{"key":"10.1016\/j.ucl.2024.07.011_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.euros.2021.07.006","article-title":"Prediction of Metastatic Patterns in Bladder Cancer: Spatiotemporal Progression and Development of a Novel, Web-based Platform for Clinical Utility","volume":"32","author":"Mason","year":"2021","journal-title":"Eur Urol Open Sci"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1148\/radiol.2020191770","article-title":"Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival","volume":"295","author":"Alessandrino","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2214\/AJR.10.5036","article-title":"Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor","volume":"196","author":"Shinagare","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.ucl.2024.07.011_bib50","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.euf.2020.01.007","article-title":"Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and Perspectives","volume":"6","author":"Gakis","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"10","key":"10.1016\/j.ucl.2024.07.011_bib51","doi-asserted-by":"crossref","first-page":"606 e9","DOI":"10.1016\/j.urolonc.2017.05.021","article-title":"Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival","volume":"35","author":"Abrahamsson","year":"2017","journal-title":"Urol Oncol"},{"issue":"21","key":"10.1016\/j.ucl.2024.07.011_bib52","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-17-1140","article-title":"Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer","volume":"23","author":"Vandekerkhove","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.ucl.2024.07.011_bib53","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41591-019-0628-7","article-title":"Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial","volume":"25","author":"Powles","year":"2019","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ucl.2024.07.011_bib54","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-020-1085-z","article-title":"Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial","volume":"26","author":"van Dijk","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ucl.2024.07.011_bib55","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1200\/JCO.2020.38.15_suppl.5012","article-title":"DUTRENEO Trial: A randomized phase II trial of DUrvalumab and TREmelimumab versus chemotherapy as a NEOadjuvant approach to muscle-invasive urothelial bladder cancer (MIBC) patients (pts) prospectively selected by an interferon (INF)-gamma immune signature","volume":"38","author":"Grande","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib56","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"Seymour","year":"2017","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2024.07.011_bib57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2024.07.011_bib58","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/bju.16191","article-title":"Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer","volume":"133","author":"Necchi","year":"2024","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2024.07.011_bib59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiographics.21.2.g01mr02451","article-title":"Urachal remnant diseases: spectrum of CT and US findings","volume":"21","author":"Yu","year":"2001","journal-title":"Radiographics"},{"issue":"10","key":"10.1016\/j.ucl.2024.07.011_bib60","first-page":"587","article-title":"[Inflammatory pseudotumor of the urinary bladder diagnosed using 3D-CT cystoscopy]","volume":"49","author":"Sakamoto","year":"2003","journal-title":"Hinyokika Kiyo"},{"issue":"12","key":"10.1016\/j.ucl.2024.07.011_bib61","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1007\/s00261-019-02276-w","article-title":"Bladder cancer and its mimics: a sonographic pictorial review with CT\/MR and histologic correlation","volume":"44","author":"Wentland","year":"2019","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"10.1016\/j.ucl.2024.07.011_bib62","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1148\/rg.262055172","article-title":"From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation","volume":"26","author":"Wong-You-Cheong","year":"2006","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib63","first-page":"199","article-title":"Mechanisms of hemorrhagic cystitis","volume":"2","author":"Haldar","year":"2014","journal-title":"Am J Clin Exp Urol"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.aju.2012.11.007","article-title":"Bladder leiomyoma: Presentation, evaluation and treatment","volume":"11","author":"Khater","year":"2013","journal-title":"Arab J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2024.07.011_bib65","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1148\/rg.2017170031","article-title":"Pearls and Pitfalls in Diagnosing Pediatric Urinary Bladder Masses","volume":"37","author":"Shelmerdine","year":"2017","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.ucl.2024.07.011_bib66","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.urology.2010.03.050","article-title":"Lymphangioma of bladder","volume":"76","author":"Niu","year":"2010","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib67","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2484\/rcr.v1i3.16","article-title":"Bladder Endometriosis: Ultrasound and MRI Findings","volume":"1","author":"Beaty","year":"2006","journal-title":"Radiol Case Rep"},{"issue":"5","key":"10.1016\/j.ucl.2024.07.011_bib68","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.euo.2019.02.002","article-title":"Predictive Role of Computed Tomography Texture Analysis in Patients with Metastatic Urothelial Cancer Treated with Programmed Death-1 and Programmed Death-ligand 1 Inhibitors","volume":"3","author":"Alessandrino","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"12","key":"10.1016\/j.ucl.2024.07.011_bib69","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1007\/s00261-021-03235-0","article-title":"Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis","volume":"46","author":"Lim","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41747-023-00321-4","article-title":"Beyond diagnosis: is there a role for radiomics in prostate cancer management?","volume":"7","author":"Stanzione","year":"2023","journal-title":"Eur Radiol Exp"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib71","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/RCT.0000000000001433","article-title":"Differentiating Benign From Malignant Cystic Renal Masses: A Feasibility Study of Computed Tomography Texture-Based Machine Learning Algorithms","volume":"47","author":"Miskin","year":"2023","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2214\/AJR.19.21709","article-title":"Radiomics of Renal Masses: Systematic Review of Reproducibility and Validation Strategies","volume":"214","author":"Kocak","year":"2020","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.ucl.2024.07.011_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102881","article-title":"Radiomics of Liver Metastases: A Systematic Review","volume":"12","author":"Fiz","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ucl.2024.07.011_bib74","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2214\/AJR.22.28582","article-title":"Beyond the AJR: CT Radiomic Features of the Pancreas Predict Development of Pancreatic Cancer","volume":"220","author":"Rosenthal","year":"2023","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib75","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s11604-023-01504-0","article-title":"CT and MRI of abdominal cancers: current trends and perspectives in the era of radiomics and artificial intelligence","volume":"42","author":"Barat","year":"2024","journal-title":"Jpn J Radiol"},{"issue":"13","key":"10.1016\/j.ucl.2024.07.011_bib76","article-title":"Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement","volume":"13","author":"Ferro","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"10.1016\/j.ucl.2024.07.011_bib77","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.euf.2021.05.005","article-title":"Role of Radiomics in the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis","volume":"8","author":"Kozikowski","year":"2022","journal-title":"Eur Urol Focus"},{"issue":"13","key":"10.1016\/j.ucl.2024.07.011_bib78","article-title":"MRI-Based Radiomics in Bladder Cancer: A Systematic Review and Radiomics Quality Score Assessment","volume":"13","author":"Boca","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ucl.2024.07.011_bib79","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3389\/fonc.2019.01296","article-title":"Study Progress of Radiomics With Machine Learning for Precision Medicine in Bladder Cancer Management","volume":"9","author":"Ge","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ucl.2024.07.011_bib80","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4764985","article-title":"Molecular Magnetic Resonance Imaging with Contrast Agents for Assessment of Inflammatory Bowel Disease: A Systematic Review","volume":"2020","author":"Luo","year":"2020","journal-title":"Contrast Media Mol Imaging"},{"issue":"1","key":"10.1016\/j.ucl.2024.07.011_bib81","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s40820-020-0396-4","article-title":"Ultra-sensitive Nanoprobe Modified with Tumor Cell Membrane for UCL\/MRI\/PET Multimodality Precise Imaging of Triple-Negative Breast Cancer","volume":"12","author":"Fang","year":"2020","journal-title":"Nano-Micro Lett"},{"issue":"24","key":"10.1016\/j.ucl.2024.07.011_bib82","article-title":"Boosting Photothermal Theranostics via TICT and Molecular Motions for Photohyperthermia Therapy of Muscle-Invasive Bladder Cancer","volume":"10","author":"Zeng","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ucl.2024.07.011_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101124","article-title":"Pre-clinical MRI-guided intravesical instillation theranosis of bladder cancer by tumor-selective oxygen nanogenerator","volume":"38","author":"Lin","year":"2021","journal-title":"Nano Today"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401432400079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401432400079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:24:20Z","timestamp":1755807860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009401432400079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S009401432400079X"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2024.07.011","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urologic Imaging of the Bladder","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2024.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}